galactosamine - CISMeF

Preferred Label : galactosamine;

MeSH CAS label : D-Galactose, 2-amino-2-deoxy-;

Registry Number MeSH : 7535-00-4;

Wikipedia link : https://en.wikipedia.org/wiki/Galactosamine;

Is substance : O;

Détails

Origin ID

D005688;

UMLS CUI

C0016943;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- deficiency [MeSH Qualifier]
- economics [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- physiology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Currated CISMeF NLP mapping
- Galactosamine [FMA entity]
- Galactosamine [LOINC component]
- Galactosamine (substance) [SNOMED CT concept]
- galactosamine [SNOMED Notion]
Record concept(s)
- galactosamine [MeSH concept]
Related MeSH Supplementary Concept(s)
- 1,5-dideoxy-1,5-iminogalactitol [MeSH Supplementary Concept]
- 2-amino-2-deoxygalactitol [MeSH Supplementary Concept]
- 3-O-methylgalactosamine [MeSH Supplementary Concept]
- 4-hydroxycinnamaldehyde-galactosamine [MeSH Supplementary Concept]
- 5-amino-5-deoxygalactopyranose [MeSH Supplementary Concept]
- C6-galactose mustard [MeSH Supplementary Concept]
- D-chiro-inositol-galactosamine [MeSH Supplementary Concept]
- DSPE-PEG-galactosamine [MeSH Supplementary Concept]
- HPMA coploymer-doxorubicin-galactosamine [MeSH Supplementary Concept]
- N-(1-azido-5-naphthalenesulfonyl)galactosamine [MeSH Supplementary Concept]
- N-(2-acetamido-3,4,6-tri-O-acetyl--2-deoxygalactopyranosyloxy)succinimide [MeSH Supplementary Concept]
- N-(4-azidosalicyl)galactosamine [MeSH Supplementary Concept]
- N-6-aminohexanoyl-alpha-galactopyranosylamine [MeSH Supplementary Concept]
- N-acetamido-3,4,6-tri-O-acetyl-2-azido-2-deoxygalactopyranosylamine [MeSH Supplementary Concept]
- N-acetyl-D-galactosamine-type gem-diamine-1-N-iminosugar [MeSH Supplementary Concept]
- N-acetylgalactosamine-diphospho-undecaprenyl [MeSH Supplementary Concept]
- N-methyl-N-nitroso-beta-D-galactosylamine [MeSH Supplementary Concept]
- N-thioglycolyl-D-galactosamine peracetate [MeSH Supplementary Concept]
- N-trifluoroacetylgalactosamine [MeSH Supplementary Concept]
- dansylgalactosamine [MeSH Supplementary Concept]
- digalactosamine [MeSH Supplementary Concept]
- doxorubicin-N-(2-hydroxypropyl)methacrylamide galactosamine conjugate [MeSH Supplementary Concept]
- galactosamine 1-phosphate [MeSH Supplementary Concept]
- galactosamine-4-phosphate [MeSH Supplementary Concept]
- galactosamine-conjugated serum albumin-conjugated-(rhodamine X)20 [MeSH Supplementary Concept]
- galactose-2-amino-6-phosphate [MeSH Supplementary Concept]
- methyl-N-dansylgalactosaminide [MeSH Supplementary Concept]
- trifluoroacetamidopropyl-2-acetamido-2-deoxygalactopyranoside [MeSH Supplementary Concept]
- tunicamine [MeSH Supplementary Concept]
- undecaprenyl phosphate-galactosamine [MeSH Supplementary Concept]
Semantic type(s)
- Biologically Active Substance [UMLS semantic type]
- Organic Chemical [UMLS semantic type]
UMLS correspondences (same concept)
- Galactosamine [LOINC component]
- Galactosamine [FMA entity]
- Galactosamine (substance) [SNOMED CT concept]
- galactosamine [SNOMED Notion]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients